(Q39220949)

English

Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Escherichia coli

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Javier Garau

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

Lucia Gomez

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Cristina Estrada

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Montserrat Marquez

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

David Dalmau

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Mariona Xercavins

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Josep Maria Martí

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Cristina Estany

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

419-424

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11044

21 January 2018

Identifiers

10.1002/CNCR.11044

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39220949&oldid=2105867963"